I'm LongbridgeAI, I can summarize articles.Merus shareholders approved Genmab's acquisition proposal, allowing Genmab's subsidiary to purchase all outstanding Merus shares at $97.00 each. The meeting also approved new non-executive directors and executive compensation related to the offer. This transaction will align Merus's operations with Genmab's strategic interests. Analysts rate MRUS stock as Hold with a $96.00 target, noting weak financial performance despite strong technical momentum.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Merus ( (MRUS) ) just unveiled an announcement.
On December 9, 2025, Merus N.V., a Dutch company, held an extraordinary general meeting where shareholders approved several proposals related to a transaction agreement with Genmab A/S. This agreement involves Genmab’s subsidiary offering to purchase all outstanding shares of Merus at $97.00 per share. The meeting saw the approval of various proposals, including the appointment of new non-executive directors and the approval of compensation for executive officers in connection with the offer. The transaction is set to impact Merus’s operations and governance, aligning it with Genmab’s strategic interests.
The most recent analyst rating on (MRUS) stock is a Hold with a $96.00 price target. To see the full list of analyst forecasts on Merus stock, see the MRUS Stock Forecast page.
Spark’s Take on MRUS Stock
According to Spark, TipRanks’ AI Analyst, MRUS is a Neutral.
Merus’s overall stock score is primarily impacted by its weak financial performance, characterized by declining revenue and substantial losses. While technical analysis indicates strong upward momentum, the overbought signals suggest caution. The negative P/E ratio further reflects the company’s financial struggles, limiting its valuation appeal.
To see Spark’s full report on MRUS stock, click here.
More about Merus
Average Trading Volume: 2,421,648
Technical Sentiment Signal: Buy
Current Market Cap: $7.29B